Article
Radical Resection for Second EGFR-mutated Primary Lung Cancer Following Immune Checkpoint Inhibitor Monotherapy for Stage IV Lung Adenocarcinoma.
Internal medicine (Tokyo, Japan) - 1 Feb 2022
Horibe Ryota, Hatakeyama Taku, Ishikawa Tatsuru, Sawai Takeyuki, Hashimoto Midori, Domen Hiromitsu, Takakuwa Yasunari, Satoh Masaaki, Nishiyama Kaoru
Abstract excerpt
A 78-year-old woman with multiple lung nodules, epithelial growth factor receptor (EGFR) exon 20 insertion mutations, and diagnosed with advanced lung adenocarcinoma (cT4N3M1a, stage IVA), was referred to our hospital. She received immune checkpoint inhibitor (ICI) therapy. The therapy showed remarkable antitumor effects; only a single nodule remained in the right upper lobe. The nodule was diagnosed as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.